A detailed history of Imc Chicago, LLC transactions in Incyte Corp stock. As of the latest transaction made, Imc Chicago, LLC holds 10,175 shares of INCY stock, worth $761,090. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,175
Previous 14,984 32.09%
Holding current value
$761,090
Previous $908,000 25.99%
% of portfolio
0.02%
Previous 0.03%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$57.33 - $68.61 $275,699 - $329,945
-4,809 Reduced 32.09%
10,175 $672,000
Q2 2024

Jul 15, 2024

SELL
$51.18 - $63.75 $142,024 - $176,906
-2,775 Reduced 15.63%
14,984 $908,000
Q1 2024

Apr 12, 2024

BUY
$56.55 - $66.59 $1 Million - $1.18 Million
17,759 New
17,759 $1.01 Million
Q1 2019

May 15, 2019

SELL
$63.56 - $88.17 $542,738 - $752,883
-8,539 Closed
0 $0
Q4 2018

Apr 24, 2019

BUY
$58.5 - $69.94 $499,531 - $597,217
8,539 New
8,539 $543,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Imc Chicago, LLC Portfolio

Follow Imc Chicago, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Imc Chicago, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Imc Chicago, LLC with notifications on news.